Internal Medicine 2008

2008 Topics

	Additional Topics
	Associates, Residents and Fellows in Training
	Cardiology
	Career and Professionalism
	Clinical Pearls
	Computer in Practice
	Clinical Pharmacology
	Ethics and Health Policy
	Endocrinology
	Gastroenterology and Hepatology
	Health Issues Related to Age and Gender
	Hematology
	Hospital Medicine
	Infectious Diseases
	Medical Practice Management
	Multiple Small Feedings of the Mind
	Nephrology and Hypertension
	Neurology
	Oncology
	Ophthalmology and Otolaryngology
	Perioperative Medicine
	Pre-Session Courses
	Psychiatry
	Pulmonary Diseases and Critical Care
	Rheumatology and Allergy & Immunology
	Updates

COX-2 Inhibitors: the Good, the Bad, and the Ugly

Session #: 858-130
Presenter(s): A. Mark Fendrick
Session Length: 1:00
Event: 2008 ACP Annual Session
Date: May 15-17, 2008

Purchase Media - Session #: 858-130
Description	Price	Qty.	Cart
MP3	$17.95		buy now
CD	$17.95		buy now
iPod Audio	$17.95		buy now
Computer AudioPoint	$24.95		buy now
iPod AudioPoint	$24.95		buy now
DOWNLOAD iPOD AUDIO FILE - COX-2 Inhibitors: the Good, the Bad, and the Ugly	$17.95		buy now
DOWNLOAD iPOD AUDIOPOINT FILE - COX-2 Inhibitors: the Good, the Bad, and the Ugly	$24.95		buy now

MTP 120
Clinical questions to be addressed:

What is the evidence for use of COX-2 inhibitors vs. NSAIDs vs. aspirin in the treatment of inflammatory conditions?
What does a risk-benefit analysis tell you about which of these drugs should be used and when?

About